Martin Shkreli fraud trial underway
Pharmaceutical exec Martin Shkreli's trial on charges of securities and wire fraud is getting underway. Jury selection is proving to be difficult, as more than 120 jurors have already been dismissed, most citing their dislike of Shkreli. CBS News justice reporter Paula Reid joins CBSN with more on the case.